Genetic investigation of sudden unexpected death in epilepsy cohort by panel target resequencing

Int J Legal Med. 2016 Mar;130(2):331-9. doi: 10.1007/s00414-015-1269-0. Epub 2015 Sep 30.

Abstract

Sudden unexpected death in epilepsy (SUDEP) is defined as the abrupt, no traumatic, witnessed or unwitnessed death, occurring in benign circumstances, in an individual with epilepsy, with or without evidence for a seizure and excluding documented status epilepticus (seizure duration ≥ 30 min or seizures without recovery), and in which postmortem examination does not reveal a cause of death. Although the physiopathological mechanisms that underlie SUDEP remain to be clarified, the genetic background has been described to play a role in this disorder. Pathogenic variants in genes associated with epilepsy and encoding cardiac ion channels could explain the SUDEP phenotype. To test this we use the next-generation sequencing technology to sequence a cohort of SUDEP cases and its translation into clinical and forensic fields. A panel target resequencing was used to study 14 SUDEP cases from both postmortem (2 cases) and from living patients (12 cases). Genes already associated with SUDEP and also candidate genes had been investigated. Overall, 24 rare genetic variants were identified in 13 SUDEP cases. Four cases showed rare variants with complete segregation in the SCN1A, FBN1, HCN1, SCN4A, and EFHC1 genes, and one case with a rare variant in KCNQ1 gene showed incomplete pattern of inheritance. In four cases, rare variants were detected in CACNA1A, SCN11A and SCN10A, and KCNQ1 genes, but familial segregation was not possible due to lack of DNA from relatives. Finally, in the four remaining cases, the rare variants did not segregate in the family. This study confirms the link between epilepsy, sudden death, and cardiac disease. In addition, we identified new potential candidate genes for SUDEP: FBN1, HCN1, SCN4A, EFHC1, CACNA1A, SCN11A, and SCN10A. Further confirmation in larger cohorts will be necessary especially if genetic screening for SUDEP is applied to forensic and clinical medicine. Nevertheless, this study supports the emerging concept of a genetically determined cardiocerebral channelopathy.

Keywords: Epilepsy; Next-generation sequencing; SUDEP; Sudden cardiac death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Calcium-Binding Proteins / genetics
  • Death, Sudden / etiology*
  • Epilepsy / genetics*
  • Female
  • Fibrillin-1 / genetics
  • Forensic Genetics
  • Genetic Variation
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels / genetics
  • KCNQ1 Potassium Channel / genetics
  • Male
  • Middle Aged
  • NAV1.1 Voltage-Gated Sodium Channel / genetics
  • NAV1.4 Voltage-Gated Sodium Channel / genetics
  • Pedigree
  • Potassium Channels / genetics
  • Young Adult

Substances

  • Calcium-Binding Proteins
  • EFHC1 protein, human
  • FBN1 protein, human
  • Fibrillin-1
  • HCN1 protein, human
  • Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
  • KCNQ1 Potassium Channel
  • KCNQ1 protein, human
  • NAV1.1 Voltage-Gated Sodium Channel
  • NAV1.4 Voltage-Gated Sodium Channel
  • Potassium Channels
  • SCN1A protein, human
  • SCN4A protein, human